PIK3CA testing and treatment patterns among patients with metastatic breast cancer in US community clinical practice

被引:0
|
作者
Kim, Eunice
Dhillon, Preet Kaur
Lambert, Peter
Cheng, Anna
Basho, Reva K.
机构
[1] Genentech Inc, San Francisco, CA USA
[2] Ellison Inst Technol, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13059
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Mutational Status of PIK3CA in Circulating Tumor Cells of Metastatic Breast Cancer Patients on Single Cell Level
    Schoemer, S.
    Meier-Stiegen, F.
    Andre, F.
    Neubauer, H.
    Janni, W.
    Wallwiener, D.
    Fehm, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 178 - 178
  • [42] PIK3CA hotspot mutations are present at a relatively high frequency in CTCs of operable and metastatic breast cancer patients
    Markou, Athina N.
    Farkona, Sofia
    Schiza, Christina
    Eftathiou, Antonia
    Malamos, Nikolaos
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian breast cancer patients
    Woldesonbet, Zelalem Desalegn
    Yohannes, Meron
    Addissie, Adamu
    Abebe, Tamrat
    Kantelhardt, Eva Johanna
    Vetter, Martina
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [45] PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer
    Marino, Elena
    Mauro, Cristian
    Belloni, Elena
    Picozzi, Marco
    Favalli, Valentina
    Cassatella, Maria Cristina
    Zorzino, Laura
    Giaco, Luciano
    Pelicci, Pier Giuseppe
    Barberis, Massimo
    Sandri, Maria Teresa
    Bernard, Loris
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [46] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
    Ruth E. Board
    Andrew M. Wardley
    J. Michael Dixon
    Anne C. Armstrong
    Sacha Howell
    Lorna Renshaw
    Emma Donald
    Alastair Greystoke
    Malcolm Ranson
    Andrew Hughes
    Caroline Dive
    Breast Cancer Research and Treatment, 2010, 120 : 461 - 467
  • [47] Adjuvant aromatase inhibitors in patients with PIK3CA mutation early breast cancer
    Reinhardt, K.
    Vetter, M.
    Kaufhold, S.
    Kantelhardt, E.
    Thomssen, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S296 - S296
  • [48] Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients
    Kumar, R.
    Agrawal, U.
    Deo, S.
    Mathur, S. R.
    Gogia, A.
    Tanwar, P.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S33 - S33
  • [49] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
    Board, Ruth E.
    Wardley, Andrew M.
    Dixon, J. Michael
    Armstrong, Anne C.
    Howell, Sacha
    Renshaw, Lorna
    Donald, Emma
    Greystoke, Alastair
    Ranson, Malcolm
    Hughes, Andrew
    Dive, Caroline
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) : 461 - 467
  • [50] Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
    Chen, Li
    Yang, Liu
    Yao, Ling
    Kuang, Xia-Ying
    Zuo, Wen-Jia
    Li, Shan
    Qiao, Feng
    Liu, Yi-Rong
    Cao, Zhi-Gang
    Zhou, Shu-Ling
    Zhou, Xiao-Yan
    Yang, Wen-Tao
    Shi, Jin-Xiu
    Huang, Wei
    Hu, Xin
    Shao, Zhi-Ming
    NATURE COMMUNICATIONS, 2018, 9